Acute leukemia
1 paper
- Humans1
Trial sponsors
Company1 trialPhase 2/3306 people
Company1 trialPhase 1/242 people
Company1 trialPhase 1/212 people
National Heart, Lung, and Blood Institute
2 trialsPhase 3625 people
2 trialsPhase 3433 people
4 trialsPhase 2/3616 people
1 trialPhase 2/340 people
Masonic Cancer Center, University of Minnesota
4 trialsPhase 2517 people
Latest
Innovation (Cambridge (Mass.))
Donor leukocyte telomere length emerges as a prognostic factor for transplantation outcomes
Cohort study of 1,049 peopleBiomarkers